BCR and metastatic malignant neoplasm in the lymph nodes: When the subgroup of patients was analyzed who had no BCP, pathological ISUP grade 1–4, and absence of lymph-node metastases (pNx/pN0) (low-risk group), only 16/833 (1.9%) experienced BCR < 1 year after RARP.